SHANGHAI, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the research, development, manufacture, marketing and distribution of probiotics dietary supplements, today announced it will host a conference call at 11:00 a.m. EST on Tuesday, November 17, 2009, to discuss the Company's financial results for the second quarter of its 2010 fiscal year.
To participate in the event by telephone, please dial 1-877-407-4134 five to 10 minutes prior to the start time (to allow time for registration) and reference the conference ID 337783. International callers should dial +1 (201) 689-8430.
A digital replay of the call will be available on Tuesday, November 17 at approximately 12:00 p.m. EST through Tuesday, November 24 at midnight EST. To listen to the replay, dial 1-877-660-6853 and enter the conference ID number 337783. International callers should dial +1-201-612-7415 and enter the same conference ID number.
The conference call will also be webcast live over the Internet and can be accessed by all interested parties at the company's Web site, http://www.chn-biotics.com .
To monitor the live webcast, please go to this web site at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. An audio replay of the event will be archived on China-Biotics' Web site at http://www.chn-biotics.com/ for 90 days.
About China-Biotics, Inc.
China-Biotics, Inc., a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit http://www.chn-biotics.com .
For more information, please contact: Eva Yan, CFO Email: firstname.lastname@example.org Web: http://www.chn-biotics.com CCG Investor Relations Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: email@example.com Web: http://www.ccgirasia.com
SOURCE China-Biotics, Inc.
|SOURCE China-Biotics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved